Market evolution: Vitamin C (CN 293627) — 2015–2025

Introduction

This report analyzes the evolution of the European Union's external trade in Vitamin C and its derivatives (Customs Code 293627) over the period 2015 to 2025. The analysis is based exclusively on the provided trade data, focusing on value, volume, pricing, partner concentration, and production dynamics. The period witnessed significant structural shifts, transforming the EU's position in the global market for this essential nutrient. Key trends include a collapse in export performance, a growing reliance on a single major supplier, and a concurrent expansion of domestic production amid intense price pressure.

1. The Reversal of Trade Fortunes: From Net Exporter to Structurally Deficit Market

The period 2015-2025 was characterized by a fundamental reversal in the EU's trade balance for Vitamin C. The bloc transitioned from a competitive exporter to a market with a significant structural trade deficit.

Export Performance Collapses While Import Demand Grows

The EU's export capacity eroded dramatically over the decade. The export value fell by 65.1%, from €123 million in 2015 to €43 million in 2025. The decline was even steeper in volume terms, with export quantities dropping by 53.7%. In contrast, import demand proved resilient, with quantities increasing by 18.5% despite a 6.1% fall in total import value, indicating a fierce price competition that reduced import costs.

The widening of the trade deficit from €112 million to €177 million underscores this structural shift. The net import reliance also increased, rising from 16.1% to 17.8%.

Traditional Export Markets Evaporated

The collapse in exports was not uniform but was driven by the near-total loss of key third-country markets. EU exports to the United States, Singapore, South Korea, and Mexico each contracted by over 90% in value between 2015 and 2025. The export profile shifted, with the United Kingdom and Switzerland becoming relatively more important, though only the UK showed absolute value growth.

2. Consolidation of Chinese Dominance in EU Supply

The most decisive trend on the import side was the significant consolidation of China's position as the EU's overwhelmingly dominant supplier, reshaping the structure of EU import dependency.

China's Market Share Increased Sharply

China's share of EU imports grew substantially. Import value from China rose by 50%, from €110 million to €165 million, even as the total import market contracted slightly. This gain occurred at the expense of other suppliers, most notably the United Kingdom, whose exports to the EU fell by 72% due to Brexit-related trade friction.

Import Dependency Became More Concentrated

The consolidation is reflected in higher import concentration. The Herfindahl-Hirschman Index (HHI) for import value increased by 23%, from 4,730 to 5,815, indicating a less diversified and more concentrated supplier base. China's stable yet low volatility (CV of 0.15) compared to other partners highlights its role as a steady, high-volume supplier, whereas smaller partners exhibited much higher trade volatility.

3. EU Production Revival Amidst Intense Price Competition

Despite the surge in imports and export collapse, the data suggests a revival and potential repositioning of the EU's domestic Vitamin C industry, though it occurred in a context of severe price pressure.

Domestic Production Value Grew

EU production value for provitamins and vitamins increased by 36.5% from 2015 to 2025, reaching €2.16 billion. This growth occurred despite a collapse in the production value minimum to €960 million in 2020, indicating volatility but a strong rebound. This suggests that EU producers may be focusing on higher-value-added segments or serving resilient domestic demand, even as they lost competitiveness in third-country export markets.

Price Pressure Squeezed Margins

The entire market was defined by declining prices. Export prices fell by 24.6%, while import prices fell by 20.8%. This uniform price decline points to intense global competition, likely driven by economies of scale from major Asian producers. The EU's specialization profile in 2025 shows the Netherlands and Germany as the most specialized EU producers, but their Revealed Symmetric Comparative Advantage (RSCA) scores are modest, indicating a sectoral competitive edge that is not overwhelming.

Conclusion

Over the 2015-2025 period, the EU's Vitamin C market underwent a profound transformation. The EU's role shifted from a net exporter to a structurally deficit market, with its export capacity in key third markets almost completely eroded. This was coupled with a significant consolidation of import dependency on China, which increased its dominance despite falling prices. Simultaneously, EU domestic production showed resilience and growth in value terms, suggesting a potential strategic reorientation. However, this repositioning occurred against a backdrop of pervasive price deflation, indicating the sector operates in a highly competitive global environment. The key dynamic is therefore a triad: collapsing exports, deepening Chinese supply dependency, and a domestic industry attempting to adapt and grow within a challenging price landscape.